Kintor Pharmaceutical Limited has announced a top-up placing of existing shares and a subscription of new shares under a general mandate. The company, along with Dr. Tong and the Vendor, has entered into an agreement with a Placing Agent. Under this agreement, the Vendor will sell, and the Placing Agent will procure purchasers to buy, on a best effort basis, 20,673,000 shares at a price of HK$2.08 per share. This represents approximately 4.62% of the company's issued share capital. Dr. Youzhi Tong, Chairman of the Board, Executive Director, and CEO of Kintor Pharmaceutical, is overseeing the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kintor Pharmaceutical Ltd. published the original content used to generate this news brief on August 01, 2025, and is solely responsible for the information contained therein.